Analysts expect Healthcare Realty Trust to report Q3 2026 revenue of $275.43 million and normalized funds from operations (FFO) of $0.41 per share, with the $17.95 stock price trading significantly below the average analyst target of $21.42.
Investors are primarily focused on the company’s Same Store Cash Net Operating Income (SSNOI) growth, which is expected to settle near 4.0% for the Q3 2026 period as occupancy comparisons stabilize.
The REIT is currently executing a large-scale capital recycling strategy, utilizing asset dispositions and a joint venture with KKR to strengthen its balance sheet and fund accretive re-investments. Recent upgrades from firms like Deutsche Bank highlight growing confidence in the company's operational execution and its ability to maintain a steady dividend despite higher interest rate headwinds.